Applying precision medicine to find a better solution

Alzheon’s ALZ-801 (valiltramiprosate) is currently the only oral anti-amyloid disease-modifying treatment in Phase 3 testing for Alzheimer’s disease. We believe that ALZ-801 has the potential to signific